Same-day test results!
Same-day test results!
¿Need an appointment?
Non-invasive prenatal testing is usually requested when the medical team considers it appropriate to expand the information obtained during pregnancy check-ups. It may be indicated due to maternal age, family history, previous screening results, ultrasound findings, or the need for an additional genetic assessment.
Because it is performed through a blood draw, it avoids invasive procedures at this stage of the study. However, its results must be interpreted as part of the full set of available tests and clinical data. If results require confirmation, the healthcare professional will indicate the appropriate next steps.
The prenatal genetic disease test using maternal blood consists of drawing blood from the pregnant person to study fragments of fetal genetic material circulating in their blood. Based on this analysis, a report is prepared that may provide information about the risk of certain genetic abnormalities.
It is considered a non-invasive test because it does not require taking a sample directly from the fetus or the placenta. Even so, it should be understood as a screening or genetic assessment tool, not as an automatic substitute for other diagnostic tests when they are necessary.
It may be recommended as part of prenatal care when additional genetic information is needed. The indication may depend on factors such as personal or family history, previous test results, ultrasound findings, or medical criteria.
It may also be considered when the pregnant person is looking for a non-invasive prenatal screening option, always after receiving appropriate information about what the test can detect, its limitations, and the correct way to interpret its results.
The test can provide an estimate of the risk of certain genetic abnormalities studied by the selected panel. The information obtained helps the medical team guide pregnancy monitoring and, when appropriate, assess the need for complementary studies.
The exact scope depends on the type of analysis requested and the clinical criteria applied. For this reason, it is important to review in advance which conditions are included and what results may be obtained.
The results must be interpreted by healthcare professionals with experience in prenatal diagnosis or genetics. A low-risk result may provide reassurance within the limits of the test, while a high-risk result usually requires specific medical assessment and, in some cases, confirmation through other techniques.
The test does not eliminate the need for ultrasound examinations, obstetric check-ups, or routine clinical pregnancy monitoring.
Counseling is an essential part of the process. Before the analysis, it helps clarify the purpose of the test, the type of information it can provide, and its limitations. Afterwards, it helps interpret the report and decide on any subsequent steps if necessary.
This support helps the pregnant person and their family make informed decisions, with a clear explanation adapted to their situation.
In our patient-centered approach, this service is presented as a support tool for making informed decisions during pregnancy. The goal is not to replace obstetric follow-up, but to complement the medical assessment with relevant genetic information, explained clearly and accompanied by qualified professionals.
Before undergoing the prenatal genetic disease test using maternal blood, it is advisable to clarify any questions about its scope, limitations, result interpretation, and possible subsequent scenarios. Every pregnancy is different, so the indication for the test and the interpretation of the report must be adapted to each person’s clinical context.
Yes. It is part of the tests known as non-invasive prenatal testing when performed through maternal blood analysis to study circulating fetal genetic material. Its purpose is to estimate the risk of certain genetic abnormalities during pregnancy.
No. The test provides genetic information, but it does not replace ultrasound examinations or routine obstetric follow-up. Both tools provide different and complementary data to assess the progress of the pregnancy.
No. A low-risk result reduces the likelihood of the abnormalities included in the analysis, but it does not rule out all genetic diseases or all possible pregnancy-related conditions. It is important to understand the specific scope of the test performed.
A high-risk result must be assessed by the specialist. Depending on the case, genetic counseling, specific follow-up, or complementary diagnostic tests may be recommended to confirm or clarify the information obtained.
Generally, since it is a blood draw, preparation is usually simple. However, specific instructions should be confirmed with the responsible center or professional, as they may vary depending on the protocol used.
The report should be interpreted by a healthcare professional, preferably within the context of prenatal follow-up. Reading the result in isolation may lead to doubts or incorrect conclusions if medical history, ultrasound findings, and the rest of the tests performed are not considered.
It is advisable to ask which abnormalities it analyzes, what limitations it has, what types of results may be obtained, whether subsequent confirmation may be required, and how the information will be integrated into pregnancy care.
Bachelor of Science in Biology from the University of Malaga and Specialist in Clinical Analysis
Laboratory Specialist Technician.
